000 | 01817 a2200505 4500 | ||
---|---|---|---|
005 | 20250513213441.0 | ||
264 | 0 | _c20000908 | |
008 | 200009s 0 0 eng d | ||
022 | _a0269-2139 | ||
024 | 7 |
_a10.1093/protein/13.6.397 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSteele, D L | |
245 | 0 | 0 |
_aExpression, characterization and structure determination of an active site mutant (Glu202-Gln) of mini-stromelysin-1. _h[electronic resource] |
260 |
_bProtein engineering _cJun 2000 |
||
300 |
_a397-405 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAmino Acid Substitution _xgenetics |
650 | 0 | 4 |
_aAminobiphenyl Compounds _xpharmacology |
650 | 0 | 4 |
_aBinding Sites _xgenetics |
650 | 0 | 4 | _aCrystallography, X-Ray |
650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGelatin _xchemistry |
650 | 0 | 4 | _aHeLa Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMatrix Metalloproteinase 3 _xbiosynthesis |
650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 | _aMutagenesis, Site-Directed |
650 | 0 | 4 |
_aProtein Binding _xphysiology |
650 | 0 | 4 | _aProtein Structure, Tertiary |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xchemistry |
700 | 1 | _aEl-Kabbani, O | |
700 | 1 | _aDunten, P | |
700 | 1 | _aWindsor, L J | |
700 | 1 | _aKammlott, R U | |
700 | 1 | _aCrowther, R L | |
700 | 1 | _aMichoud, C | |
700 | 1 | _aEngler, J A | |
700 | 1 | _aBirktoft, J J | |
773 | 0 |
_tProtein engineering _gvol. 13 _gno. 6 _gp. 397-405 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/protein/13.6.397 _zAvailable from publisher's website |
999 |
_c10828509 _d10828509 |